Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus

Abstract

Background

LupusPRO is a SLE specific patient reported outcomes measure developed and validated in the USA. This study aimed to validate the Hindi version of LupusPRO in systemic lupus erythematosus (SLE) patients in India.

Methods

Disease activity and damage were assessed using SELENA–SLEDAI and SLICC/ACR damage Index respectively. Demographic and clinical features were recorded. The Hindi Version of LupusPRO and 36-Item Short Form Health Survey (SF-36) were administered for assessment of quality of life. Depression, anxiety and fatigue were assessed using Patient Health Questionnaire 9 (PHQ9), Generalized Anxiety Disorder 7 (GAD7) and Fatigue Severity Scale (FSS) respectively. Internal consistency reliability, test-retest reliability, convergent and discriminant validity (against corresponding domains of the SF-36, fatigue, depression and anxiety), criterion validity (against disease activity and damage) and known group validity were tested.

Results

A total of 144 (140 females) patients with SLE with a mean age of 32.48 ± 7.26 years participated in the study. The median (interquartile range) SELENA SLEDAI was 2 (5.5). The internal consistency reliability of the LupusPRO domains was >0.7 for most domains (except for lupus symptoms, lupus medication, procreation and social support).We noted good convergent validity of LupusPRO domains with corresponding domains of SF-36, pain vitality with fatigue (FSS) and emotional health domain with depression (PHQ9) and anxiety (GAD7). Criterion validity of lupus symptoms with disease activity was observed. Known group validity of the LupusPRO domains with patient reported health status was observed. Confirmatory factor analysis showed a good fit.

Conclusion

The Hindi LupusPRO has fair psychometric properties among Indian patients with SLE.

Keywords

SLE quality of life patient reported outcomes LupusPRO

Get full access to this article

View all access options for this article.

References

Tektonidou

Lewandowski

Dasgupta

Ward

. Survival in adults and children with systemic lupus erythematosus: A systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 2017; 76: 2009–2016.

Mahieu

Yount

Ramsey-Goldman

. Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin North Am 2016; 42: 253–263.

Schmeding

Schneider

. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2013; 27: 363–375.

Jolly

Pickard

Block

, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 2012; 42: 56–65.

Petri

Orbai

A-M

Alarcón

, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677–2686.

Petri

Kim

Kalunian

, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353: 2550–2558.

Gladman

Ginzler

Goldsmith

, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

Krupp

LaRocca

Muir-Nash

Steinberg

. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.

Kroenke

Spitzer

Williams

. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613.

10.

Spitzer

Kroenke

Williams

JBW, Löwe B

. A brief measure for assessing generalized anxiety disorder. Arch Intern Med 2006; 166: 1092.

11.

Maruish

. User’s manual for the SF-36v2 Health Survey, 3rd ed. Lincoln, RI: Quality Metric Incorporated, 2011.

12.

Sinha

van den Heuvel

WJA

Arokiasamy

. Validity and reliability of MOS Short Form Health Survey (SF-36) for use in India. Indian J Community Med 2013; 38: 22–26.

13.

Bourré-Tessier

Clarke

Kosinski

, et al. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus 2014; 23: 1452–1459.

14.

Seymour

McNamee

Scott

Tinelli

. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ 2010; 19: 683–696.

15.

Bourre-Tessier

Clarke

Mikolaitis-Preuss

, et al. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol 2013; 40: 1327–1333.

16.

Bentler

. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Model A Multidiscip J 1999; 6: 1–55.

17.

Navarra

Tanangunan

Mikolaitis-Preuss

Kosinski

Block

Jolly

. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus 2013; 22: 262–267.

18.

Jolly

Toloza

Block

, et al. Spanish LupusPRO: ross-cultural validation study for lupus. Lupus 2013; 22: 431–436.

19.

Kaya

Goker

Cura

, et al. Turkish LupusPRO: Cross-cultural validation study for lupus. Clin Rheumatol 2014; 33: 1079–1084.

20.

Mok

Kosinski

Chan

Jolly

. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2015; 67: 297–304.

21.

Inoue

Shiozawa

Yoshihara

, et al. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus 2017; 26: 849–856.

22.

McElhone

Abbott

Shelmerdine

, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 972–979.

23.

Leong

Kong

Thong

BYH

, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology 2005; 44: 1267–1276.